Reimagining academic and biopharma R&D with agile, science-driven consulting. Helping visionary teams to accelerate breakthrough therapies from idea to impact.

Target and asset evaluation for translational readiness

Preclinical strategy and study design across modalities

Pipeline review and program prioritization

Cross-functional coordination to bridge research through development

Scientific storytelling to communicate value to stakeholders and investors